Mohammed Er-rajy

684 total citations
36 papers, 458 citations indexed

About

Mohammed Er-rajy is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mohammed Er-rajy has authored 36 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Computational Theory and Mathematics, 18 papers in Organic Chemistry and 16 papers in Molecular Biology. Recurrent topics in Mohammed Er-rajy's work include Computational Drug Discovery Methods (20 papers), Synthesis and biological activity (16 papers) and Cancer therapeutics and mechanisms (6 papers). Mohammed Er-rajy is often cited by papers focused on Computational Drug Discovery Methods (20 papers), Synthesis and biological activity (16 papers) and Cancer therapeutics and mechanisms (6 papers). Mohammed Er-rajy collaborates with scholars based in Morocco, Saudi Arabia and India. Mohammed Er-rajy's co-authors include Mohamed El fadili, Menana Elhallaoui, Sara Zarougui, Hamada Imtara, Somdutt Mujwar, Mohammed Kara, Omkulthom Al kamaly, Amine Assouguem, Hanine Hadni and Omar M. Noman and has published in prestigious journals such as Scientific Reports, RSC Advances and Colloids and Surfaces A Physicochemical and Engineering Aspects.

In The Last Decade

Mohammed Er-rajy

32 papers receiving 450 citations

Peers

Countries citing papers authored by Mohammed Er-rajy

Since Specialization

Citations

This map shows the geographic impact of Mohammed Er-rajy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Er-rajy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Er-rajy more than expected).

Fields of papers citing papers by Mohammed Er-rajy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Er-rajy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Er-rajy. The network helps show where Mohammed Er-rajy may publish in the future.

Co-authorship network of co-authors of Mohammed Er-rajy

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Er-rajy. A scholar is included among the top collaborators of Mohammed Er-rajy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Er-rajy. Mohammed Er-rajy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In-depth study of the nutritional composition, phytochemicals, antioxidant activity, molecular docking interactions, and toxicological evaluation of Abies marocana Trab. woody biomass 2025 ·Frontiers in Sustainable Food Systems ·(unknown), (unknown), (unknown), Mohammed Er-rajy, Hamada Imtara, (unknown), (unknown), Omar M. Noman, (unknown), Driss Hmouni, (unknown)	1
2	DFT computation-assisted design and synthesis of trisodium nickel triphosphate: Crystal structure, vibrational study, electronic properties and application in wastewater purification 2025 ·Journal of Molecular Structure ·(unknown), Mohammed Er-rajy, Khalil Azzaoui, Rachid Sabbahi, Ghadir Hanbali, Shehdeh Jodeh, Solhe F. Alshahateet, Belkheir Hammouti, Savaş Kaya, Mikhail M. Maslov, Mohammed Lachkar, (unknown)	2
3	Chemical profiling, safety assessment, bioactive properties, and molecular interactions of the essential oil derived from Mentha pulegium L. 2025 ·Frontiers in Sustainable Food Systems ·(unknown), Amar Habsaoui, (unknown), Mohammed Er-rajy, (unknown), Hamada Imtara, Asmaa Oubihi, (unknown), (unknown), Omar M. Noman, (unknown), (unknown), M. Ebn Touhamı	1
4	An in-depth study of indolone derivatives as potential lung cancer treatment 2025 ·Scientific Reports ·Mohammed Er-rajy, Mohamed El fadili, Radwan Alnajjar, Sara Zarougui, Somdutt Mujwar, Khalil Azzaoui, Hatem A. Abuelizz, B. Hammouti, Menana Elhallaoui	1
5	In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease 2025 ·Scientific Reports ·(unknown), Mohamed El fadili, Somdutt Mujwar, Mohammed Er-rajy, Hatem A. Abuelizz, (unknown), Sara Zarougui, (unknown)	2
6	Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study 2025 ·Frontiers in Chemistry ·Mohammed Er-rajy, Mohamed El fadili, Sara Zarougui, Somdutt Mujwar, (unknown), (unknown), Belkheir Hammouti, Larbi Rhazi, Rachid Sabbahi, Mohammed M. Alanazi, Khalil Azzaoui, R. Salghi, Menana Elhallaoui	4
7	Inhibition of carbohydrate digestive enzymes by a complementary essential oil blend: in silico and mixture design approaches 2025 ·Frontiers in Pharmacology ·El Hassania Loukili, Mouhcine Fadil, (unknown), Mohammed Er-rajy, Mohamed Taibi, Khalil Azzaoui, R. Salghi, Rachid Sabbahi, (unknown), Larbi Rhazi, Aleksandar Széchenyi, Mohamed Siaj, B. Hammouti	1
8	Chromone-isoxazole derivatives as corrosion inhibitors for mild steel in 1 M HCl solution: Experimental, DFT and DFTB approaches 2025 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·Elhachmia Ech‐chihbi, (unknown), Rajae Salim, Mohammed Er-rajy, R. Salghi, (unknown), Moussa Ouakki, Khalil Azzaoui, Walid Ettahiri, Ashwag S. Alanazi, Ghali Al Houari, B. Hammouti	12
9	Green Synthesis of Zinc Oxide Nanoparticles for Tetracycline Adsorption: Experimental Insights and DFT Study 2024 ·Plants ·Solhe F. Alshahateet, (unknown), Mohammed Er-rajy, (unknown), Khalil Azzaoui, (unknown), B. Hammouti, R. Salghi, Rachid Sabbahi, Mohammed M. Alanazi, Larbi Rhazi	0
10	Design, synthesis, characterization, and theoretical calculations, along with in silico and in vitro antimicrobial proprieties of new isoxazole-amide conjugates 2024 ·Open Chemistry ·(unknown), (unknown), Mohammed Er-rajy, (unknown), (unknown), (unknown), Burak Tüzün, Asmae Nakkabi, Mohammed Chalkha, Mohammed El Hassouni, Atul Kabra, (unknown), A. Baouid, Mohamed El Yazidi	8
11	New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies 2024 ·RSC Advances ·(unknown), Mohammad Y. Alfaifi, (unknown), Serag Eldin I. Elbehairi, Mohammed Er-rajy, Reda F.M. Elshaarawy, Yasser A. Hassan, (unknown)	0
12	In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations 2024 ·BMC Chemistry ·Mohamed El fadili, Mohammed Er-rajy, Somdutt Mujwar, (unknown), (unknown), Mohammed Kara, Hatem A. Abuelizz, (unknown), Menana Elhallaoui	14
13	Inhibitory potency of active metabolites from different polarities of Datura Stramonium seed extracts: GC-MS analysis, biological evaluations, and molecular docking studies 2024 ·Journal de Mycologie Médicale ·(unknown), Azeddin El Barnossi, Mohammed Er-rajy, (unknown), Ana Grenha, (unknown), Tarik Ainane, (unknown), Zakia Rais	1
14	Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation 2023 ·Journal of Biomolecular Structure and Dynamics ·Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, Sara Zarougui, Menana Elhallaoui	40
15	3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer 2023 ·Life ·Mohammed Er-rajy, Mohamed El fadili, Hamada Imtara, (unknown), (unknown), Sara Zarougui, (unknown), (unknown), Mohammad Khalid Parvez, Menana Elhallaoui	22
16	Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation 2023 ·Anti-Cancer Drugs ·Mohammed Er-rajy, Mohamed El fadili, (unknown), Sara Zarougui, Menana Elhallaoui	9
17	Molecular Docking and QSAR Studies for Modeling the Inhibitory Activity of Pyrazole-benzimidazolone Hybrids as Novel Inhibitors of Human 4-hydroxyphenylpyruvate dioxygenase Against Type I Tyrosinemia Disease 2022 ·Biointerface Research in Applied Chemistry ·(unknown), Hanae Naceiri Mrabti, Mohammed Er-rajy, (unknown), Latifa Doudach, (unknown), Abdelhakim Bouyahya, Gökhan Zengin, Menana Elhallaoui, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
18	QSAR, molecular docking, ADMET properties in silico studies for a series of 7-propanamide benzoxaboroles as potent anti-cancer agents 2022 ·Chinese Journal of Analytical Chemistry ·Mohammed Er-rajy, Mohamed El fadili, (unknown), Sara Zarougui, Menana Elhallaoui	22
19	2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives 2022 ·Structural Chemistry ·Mohammed Er-rajy, Mohamed El fadili, Hanine Hadni, (unknown), Sara Zarougui, Menana Elhallaoui	40
20	QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia 2022 ·Pharmaceuticals ·Mohamed El fadili, Mohammed Er-rajy, Mohammed Kara, Amine Assouguem, Assia Belhassan, Amal Alotaibi, (unknown), Hafize Fidan, Riaz Ullah, Sezai Erċışlı, Sara Zarougui, Menana Elhallaoui	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact